GSK369796 Dihydrochloride
featured

    WARNING: This product is for research use only, not for human or veterinary use.

MedKoo CAT#: 530320

CAS#: 1010411-21-8 (HCl)

Description: GSK369796, also known as N-tert-butylisoquine, is an anti-malaria drug candidate. GSK369796 was rationally designed based on chemical, toxicological, pharmacokinetic, and pharmacodynamic considerations and was selected based on excellent activity against Plasmodium falciparum in vitro and rodent malaria parasites in vivo.

Chemical Structure

img
GSK369796 Dihydrochloride
CAS# 1010411-21-8 (HCl)
Product data Instruction

Theoretical Analysis

MedKoo Cat#: 530320
Name: GSK369796 Dihydrochloride
CAS#: 1010411-21-8 (HCl)
Chemical Formula: C20H24Cl3N3O
Exact Mass: 0.00
Molecular Weight: 428.782
Elemental Analysis: C, 56.02; H, 5.64; Cl, 24.80; N, 9.80; O, 3.73

Price and Availability

Size Price Availability Quantity
5mg USD 330 2 Weeks
10mg USD 550 2 Weeks
25mg USD 950 2 Weeks
50mg USD 1450 2 Weeks
100mg USD 2450 2 Weeks
Bulk inquiry

Related CAS #: 459133-38-1 (free base)   1010411-21-8 (HCl)    

Synonym: GSK369796 Dihydrochloride; GSK 369796; GSK-369796; GSK369796; N-tert-Butyl isoquine.

IUPAC/Chemical Name: 2-[(tert-Butylamino)methyl]-5-[(7-chloroquinolin-4-yl)amino]phenol Dihydrochloride

InChi Key: UDVALKJFXQVZSI-UHFFFAOYSA-N

InChi Code: InChI=1S/C20H22ClN3O.2ClH/c1-20(2,3)23-12-13-4-6-15(11-19(13)25)24-17-8-9-22-18-10-14(21)5-7-16(17)18;;/h4-11,23,25H,12H2,1-3H3,(H,22,24);2*1H

SMILES Code: OC1=CC(NC2=CC=NC3=CC(Cl)=CC=C23)=CC=C1CNC(C)(C)C.[H]Cl.[H]Cl

Appearance: Solid powder

Purity: >98% (or refer to the Certificate of Analysis)

Shipping Condition: Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Solubility: Soluble in DMSO

Shelf Life: >2 years if stored properly

Drug Formulation: This drug may be formulated in DMSO

Stock Solution Storage: 0 - 4 C for short term (days to weeks), or -20 C for long term (months).

HS Tariff Code: 2934.99.9001

More Info:

Product Data:
Product Data
Instruction:
View handling instruction
Biological target: GSK369796 Dihydrochloride is an affordable and effective antimalarial and inhibits hERG potassium ion channel repolarization with an IC50 of 7.5 μM.
In vitro activity: It is also clear that N-tert-butyl analogue 2k (GSK369796 Dihydrochloride) is potent against chloroquine resistant strains, though it is not quite as active as amodiaquine against both chloroquine-sensitive and resistant parasites. On the basis of the activity presented in Table 4, 2k was selected alongside its direct 4-chloro analogue for further studies in the mouse model of malaria. Reference: J Med Chem. 2009 Apr 9;52(7):1828-44. https://pubmed.ncbi.nlm.nih.gov/19284751/
In vivo activity: The therapeutic efficacy of 2k (GSK369796 Dihydrochloride), 3k, and selected 4-aminoquinolines was evaluated in a standard “4-day test” in CD1 mice infected intravenously with the murine pathogen P berghei ANKA at GSK, Tres Cantos, Spain (Table 5). Isoquine (1d) showed in vivo therapeutic efficacy against Plasmodium berghei ANKA with ED50 and ED90 in the same range as that of amodiaquine. Analogue 2k was also potent in this in vivo assay with an ED50 value of 5.3 mg/kg, whereas chloro analogue 3k was less potent with an ED50 of 13.4 mg/ kg. Reference: J Med Chem. 2009 Apr 9;52(7):1828-44. https://pubmed.ncbi.nlm.nih.gov/19284751/

Solubility Data

Solvent Max Conc. mg/mL Max Conc. mM
Solubility
DMSO 100.0 233.22
Water 50.0 116.61

Preparing Stock Solutions

The following data is based on the product molecular weight 428.78 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
Formulation protocol: 1. O'Neill PM, Shone AE, Stanford D, Nixon G, Asadollahy E, Park BK, Maggs JL, Roberts P, Stocks PA, Biagini G, Bray PG, Davies J, Berry N, Hall C, Rimmer K, Winstanley PA, Hindley S, Bambal RB, Davis CB, Bates M, Gresham SL, Brigandi RA, Gomez-de-Las-Heras FM, Gargallo DV, Parapini S, Vivas L, Lander H, Taramelli D, Ward SA. Synthesis, antimalarial activity, and preclinical pharmacology of a novel series of 4'-fluoro and 4'-chloro analogues of amodiaquine. Identification of a suitable "back-up" compound for N-tert-butyl isoquine. J Med Chem. 2009 Apr 9;52(7):1828-44. doi: 10.1021/jm8012757. PMID: 19284751.
In vitro protocol: 1. O'Neill PM, Shone AE, Stanford D, Nixon G, Asadollahy E, Park BK, Maggs JL, Roberts P, Stocks PA, Biagini G, Bray PG, Davies J, Berry N, Hall C, Rimmer K, Winstanley PA, Hindley S, Bambal RB, Davis CB, Bates M, Gresham SL, Brigandi RA, Gomez-de-Las-Heras FM, Gargallo DV, Parapini S, Vivas L, Lander H, Taramelli D, Ward SA. Synthesis, antimalarial activity, and preclinical pharmacology of a novel series of 4'-fluoro and 4'-chloro analogues of amodiaquine. Identification of a suitable "back-up" compound for N-tert-butyl isoquine. J Med Chem. 2009 Apr 9;52(7):1828-44. doi: 10.1021/jm8012757. PMID: 19284751.
In vivo protocol: 1. O'Neill PM, Shone AE, Stanford D, Nixon G, Asadollahy E, Park BK, Maggs JL, Roberts P, Stocks PA, Biagini G, Bray PG, Davies J, Berry N, Hall C, Rimmer K, Winstanley PA, Hindley S, Bambal RB, Davis CB, Bates M, Gresham SL, Brigandi RA, Gomez-de-Las-Heras FM, Gargallo DV, Parapini S, Vivas L, Lander H, Taramelli D, Ward SA. Synthesis, antimalarial activity, and preclinical pharmacology of a novel series of 4'-fluoro and 4'-chloro analogues of amodiaquine. Identification of a suitable "back-up" compound for N-tert-butyl isoquine. J Med Chem. 2009 Apr 9;52(7):1828-44. doi: 10.1021/jm8012757. PMID: 19284751.

Molarity Calculator

Calculate the mass, volume, or concentration required for a solution.
=
x
x
g/mol

*When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and SDS / CoA (available online).

Reconstitution Calculator

The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial. Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.

=
÷

Dilution Calculator

Calculate the dilution required to prepare a stock solution.
x
=
x

1: O'Neill PM, Shone AE, Stanford D, Nixon G, Asadollahy E, Park BK, Maggs JL,
Roberts P, Stocks PA, Biagini G, Bray PG, Davies J, Berry N, Hall C, Rimmer K,
Winstanley PA, Hindley S, Bambal RB, Davis CB, Bates M, Gresham SL, Brigandi RA,
Gomez-de-Las-Heras FM, Gargallo DV, Parapini S, Vivas L, Lander H, Taramelli D,
Ward SA. Synthesis, antimalarial activity, and preclinical pharmacology of a
novel series of 4'-fluoro and 4'-chloro analogues of amodiaquine. Identification
of a suitable "back-up" compound for N-tert-butyl isoquine. J Med Chem. 2009 Apr
9;52(7):1828-44. doi: 10.1021/jm8012757. PubMed PMID: 19284751.


2: O'Neill PM, Park BK, Shone AE, Maggs JL, Roberts P, Stocks PA, Biagini GA,
Bray PG, Gibbons P, Berry N, Winstanley PA, Mukhtar A, Bonar-Law R, Hindley S,
Bambal RB, Davis CB, Bates M, Hart TK, Gresham SL, Lawrence RM, Brigandi RA,
Gomez-delas-Heras FM, Gargallo DV, Ward SA. Candidate selection and preclinical
evaluation of N-tert-butyl isoquine (GSK369796), an affordable and effective
4-aminoquinoline antimalarial for the 21st century. J Med Chem. 2009 Mar
12;52(5):1408-15. doi: 10.1021/jm8012618. PubMed PMID: 19222165.